CalciMedica, Inc.
CALC· Nasdaq
Filed Aug 12, 2021 · 10-Q · 43 days after period end · 0001564590-21-044001
| Metric | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|
| Net Income | -$7.71M | -$5.87M | -$10.26M |
| EPS Diluted | -$0.36 | -$6.79 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CalciMedica, Inc. · CIK 1534133 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end